228 related articles for article (PubMed ID: 25638419)
1. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation.
Gao Y; Li Z; Xie X; Wang C; You J; Mo F; Jin B; Chen J; Shao J; Chen H; Jia L
Eur J Pharm Sci; 2015 Apr; 70():55-63. PubMed ID: 25638419
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
[TBL] [Abstract][Full Text] [Related]
3. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
4. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
5. Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells.
Lv T; Yu T; Fang Y; Zhang S; Jiang M; Zhang H; Zhang Y; Li Z; Chen H; Gao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():182-190. PubMed ID: 28415453
[TBL] [Abstract][Full Text] [Related]
6. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
7. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
8. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
[TBL] [Abstract][Full Text] [Related]
9. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
Shi Y; Su C; Cui W; Li H; Liu L; Feng B; Liu M; Su R; Zhao L
J Nanobiotechnology; 2014 Oct; 12():43. PubMed ID: 25358257
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
[TBL] [Abstract][Full Text] [Related]
11. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
12. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J
J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340
[TBL] [Abstract][Full Text] [Related]
13. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
14. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X
Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor.
Nkepang G; Bio M; Rajaputra P; Awuah SG; You Y
Bioconjug Chem; 2014 Dec; 25(12):2175-88. PubMed ID: 25351441
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor-targeted multimodal fluorescence mesosilica nanoparticles for imaging, delivery palladium complex and in vitro G-quadruplex DNA interaction.
Poshteh Shirani M; Rezaei B; Khayamian T; Dinari M; Karami K; Mehri-Lighvan Z; Hosseini Shamili F; Ramazani M; Alibolandi M
J Biomol Struct Dyn; 2018 Dec; 36(16):4156-4169. PubMed ID: 29188757
[TBL] [Abstract][Full Text] [Related]
20. Folic acid-conjugated iron oxide porous nanorods loaded with doxorubicin for targeted drug delivery.
Yu P; Xia XM; Wu M; Cui C; Zhang Y; Liu L; Wu B; Wang CX; Zhang LJ; Zhou X; Zhuo RX; Huang SW
Colloids Surf B Biointerfaces; 2014 Aug; 120():142-51. PubMed ID: 24907583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
